FONDAZIONE TOSCANA GABRIELE MONASTERIO
🇮🇹Italy
Clinical Trials
17
Active:9
Completed:0
Trial Phases
3 Phases
Phase 1:8
Phase 3:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
8 (66.7%)Not Applicable
3 (25.0%)Phase 3
1 (8.3%)Health Improvements by Understanding the Determinants of Residual Risk in Coronary Artery Disease and New Targets for Prevention and Treatment
Recruiting
- Conditions
- Coronary Arterial Disease (CAD)
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Fondazione Toscana Gabriele Monasterio
- Target Recruit Count
- 961
- Registration Number
- NCT06601153
- Locations
- 🇮🇹
Irccs Synlab Sdn, Napoli, Italy
🇮🇹Fondazione Toscana Gabriele Monasterio, Pisa, Italy
TRAnscutaneous vaGUS Nerve Stimulation in Patients With Chronic Heart Failure
Not Applicable
Not yet recruiting
- Conditions
- Heart Failure With Midrange Ejection FractionHeart FailureHeart Failure With Reduced Ejection Fraction
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Fondazione Toscana Gabriele Monasterio
- Target Recruit Count
- 24
- Registration Number
- NCT06355388
- Locations
- 🇮🇹
Michele Emdin, Pisa, Pi, Italy
18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis
Not Applicable
Recruiting
- Conditions
- AmyloidAmyloid Cardiomyopathy
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Fondazione Toscana Gabriele Monasterio
- Target Recruit Count
- 150
- Registration Number
- NCT06048601
- Locations
- 🇮🇹
Fondazione Toscana Gabriele Monasterio, Pisa, Italy
Ultrasound-guided Femoral Puncture to Reduce Access- Related Complications After TAVR: (ACCESS-TAVR SIRIO)
Not Applicable
Recruiting
- Conditions
- Transcatheter Aortic Valve Replacement
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Fondazione Toscana Gabriele Monasterio
- Target Recruit Count
- 508
- Registration Number
- NCT05637983
- Locations
- 🇮🇹
Fondazione Toscana Gabriele Monasterio, Massa, MS, Italy
Preconditioning With Sevoflurane and Propofol in Patients Undergoing Minimally Invasive Mitral Valve Surgery
- Conditions
- Myocardial Ischemia
- Interventions
- Drug: sevofluorane
- First Posted Date
- 2015-09-16
- Last Posted Date
- 2015-09-16
- Lead Sponsor
- Fondazione Toscana Gabriele Monasterio
- Target Recruit Count
- 48
- Registration Number
- NCT02551328
- Locations
- 🇮🇹
Ospedale del cuore, Pasquinucci Hospital, Fondazione Monasterio, Massa, Italy
- Prev
- 1
- 2
- Next
News
No news found